MRI影像组学在肝细胞癌进展、复发与预后预测方面的研究进展

Research progress on MRI radiomics in the progression,recurrence and prognosis prediction of hepatocellular carcinoma

原发性肝癌在世界因癌症死亡主要原因中排名第三,其中最常见的是肝细胞癌。大多数情况下,肝细胞癌确诊时已是晚期,预后较差。MRI影像组学技术可以将影像信息以及临床风险因素联合构建组合模型,对肝细胞癌患者进行术前预测与术后评估。本文综述了MRI影像组学在肝细胞癌患者微血管侵犯、预测复发、疗效评估和生存分析方面的应用潜力,展示了MRI影像组学模型具有较好的预测能力,可指导患者与临床医生选择合适的治疗方案,从而提高患者生存率,并希望能为未来的科研工作提供更多的新思路与新方向。

Primary liver cancer ranks third among the world's leading causes of cancer death,with hepatocellular carcinoma being the most common.In most cases,the cancer is advanced when hepatocellular carcinoma is diagnosed,so the prognosis for hepatocellular carcinoma is usually poor.MRI radiomics technology can combine imaging information and clinical risk factors to build a combination model for preoperative prediction and postoperative evaluation of hepatocellular carcinoma patients.This article reviews the application potential of MRI radiomics in microvascular invasion,prediction of recurrence,efficacy assessment and survival analysis in patients with hepatocellular carcinoma,and shows that MRI radiomics models have good predictive ability,guide patients and clinicians to choose the appropriate treatment plan to improve the survival rate of patients,and hope to provide more new ideas and new directions for future scientific research.